Pro-inflammatory signaling pathways in gingival cells

Pro-inflammatory signaling pathways in gingival cells, including gingival fibroblasts and epithelial cells, encompass a complex network of intracellular events that drive the host response to periodontal pathogens such as Porphyromonas gingivalis. Key pathways involved include the Nuclear Factor-kappa B (NF-κB) pathway, Mitogen-Activated Protein Kinase (MAPK) cascades (p38, JNK, and ERK), and the NLRP3 inflammasome, which are typically activated by Toll-like receptors (TLRs) recognizing pathogen-associated molecular patterns (PMID: 31434172, 28815325). Activation of these pathways leads to the transcription and secretion of various inflammatory mediators, such as cytokines (IL-1β, IL-6, TNF-α) and matrix metalloproteinases (MMPs), which are responsible for the degradation of the extracellular matrix and alveolar bone (PMID: 30105615). While these pathways are vital for the acute immune response to infection, their chronic and dysregulated activation is the primary driver of tissue destruction in periodontitis (NIH: Periodontal Disease). Therapeutic interventions often target specific components of these pathways, such as Janus kinases (JAK) or specific cytokines, to resolve inflammation and prevent disease progression. However, because this term describes a broad biological process rather than a single molecular entity, it is considered a pathway group rather than a specific therapeutic target.

Other names

Gingival inflammatory signalingPeriodontal pro-inflammatory cascadesCytokine signaling in gingival fibroblastsTLR-mediated signaling in oral mucosa

Inhibition of intracellular signaling cascades (e.g., JAK/STAT, MAPK), antagonism of pro-inflammatory cytokines (e.g., TNF-alpha), and suppression of transcription factor translocation (e.g., NF-kappa B) to reduce the production of inflammatory mediators.